|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-05-09 Purchase |
2008-05-12 11:15 am | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 4,000 | $6.676 | $26,702 | 21,763 (Direct) | View |
| 2007-07-03 Sale |
2007-07-06 4:13 pm | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 3,467 | $12.3 | $42,640 | 17,763 (Direct) |
View |
| 2003-09-15 Purchase |
2003-09-16 09:10 am |
GENTA INC DE | GNTA | KEANE WILLIAM P (Chief Financial Officer) | 2,000 | $14 | $28,000 | 6,000 (Direct) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2009-07-01 Option Award Tax Withholding | 2009-07-06 4:38 pm | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 16,515 | $2.603 | $42,984 | 39,073 (Direct) |
View |
| 2008-07-01 Option Award Tax Withholding |
2008-07-03 09:28 am | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 15,847 | $1.407 | $22,292 | 31,268 (Direct) | View |
| 2007-07-01 Option Award | 2007-07-03 5:08 pm |
SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 9,230 | $0 | $0 | 21,230 (Direct) | View |
| 2006-07-13 Option Award | 2006-07-17 5:53 pm | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 10,000 | $0 | $0 | 12,000 (Direct) | View |
| 2006-02-28 Option Award | 2006-03-01 4:42 pm | SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 2,000 | $15.95 | $31,898 | 2,000 (Direct) |
View |
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2005-06-09 Option Award |
2005-06-13 4:55 pm | N/A 2015-06-09 |
SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 15,000 | $17.63 | 15,000 (Direct) |
View |
| 2005-04-11 Option Award |
2005-04-13 4:02 pm |
2006-04-11 2015-04-11 |
GENTA INC DE | GNTA | KEANE WILLIAM P (Sr. VP, CFO & Corp. Secretary) | 25,000 | $0.92 | 25,000 (Direct) |
View |
| 2005-03-24 Option Award |
2005-03-25 3:32 pm |
2006-03-24 2015-03-24 | GENTA INC DE | GNTA | KEANE WILLIAM P (VP, CFO & Corporate Secretary) | 25,000 | $1.15 | 25,000 (Direct) |
View |
| 2005-01-07 Option Award | 2005-01-11 4:40 pm | 2006-01-07 2015-01-07 | GENTA INC DE | GNTA | KEANE WILLIAM P (VP, CFO & Corporate Secretary) | 35,000 | $1.62 | 35,000 (Direct) |
View |
| 2004-06-17 Option Award |
2004-07-07 3:37 pm | N/A 2014-06-17 |
SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 15,000 | $28.31 | 15,000 (Direct) | View |
| 2004-06-30 Option Award |
2004-07-01 6:24 pm | 2005-06-30 2014-06-30 |
GENTA INC DE | GNTA | KEANE WILLIAM P (VP, CFO & Corporate Secretary) | 30,000 | $2.5 | 30,000 (Direct) | View |
| 2004-01-14 Option Award | 2004-01-14 4:47 pm |
N/A 2014-01-14 |
SALIX PHARMACEUTICALS LTD | SLXP | KEANE WILLIAM P (Director) | 20,000 | $22.87 | 20,000 (Direct) | View |
| 2004-01-05 Option Award |
2004-01-09 2:34 pm | 2005-01-05 2014-01-05 |
GENTA INC DE | GNTA | KEANE WILLIAM P (Chief Financial Officer) | 35,000 | $10.32 | 35,000 (Direct) |
View |
| 2003-07-01 Option Award |
2003-08-11 5:18 pm |
2004-07-01 2013-07-01 |
GENTA INC DE | GNTA | KEANE WILLIAM P (Chief Financial Officer) | 15,000 | $13.23 | 15,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 21:07:42 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |